This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

John R. Person, MD; Roy S. Rogers III, MD

Arch Dermatol. 1977;113(5):610-615.

Abstract
• Since 1968, a total of 84 patients with bullous pemphigoid have been seen at the Mayo Clinic. Of these, 41 were given a trial of sulfapyridine or dapsone, and six showed a significant response. In five patients, the condition was controlled completely. All responsive patients showed indirect and direct immunofluorescent tests indistinguishable from typical bullous pemphigoid. The patients, however, were somewhat younger (mean 54 years) than others having pemphigoid; and in two patients, biopsy specimens showed a reversal of the usual eosinophilic predominance over neutrophils. Three of the six patients were also diabetic.

(Arch Dermatol 113:610-615, 1977)

Author Affiliations
From the Mayo Clinic and Mayo Foundation, Rochester, Minn.

Footnotes
Accepted for publication July 21, 1976.

Reprint requests to Section of Publications, Mayo Clinic, 200 First St SW, Rochester, MN 55901 (Dr Person).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Consensus Statement on the Use of Intravenous Immunoglobulin Therapy in the Treatment of Autoimmune Mucocutaneous Blistering Diseases
Ahmed and Dahl
Arch Dermatol 2003;139:1051-1059.
ABSTRACT | FULL TEXT  

Bullous Pemphigoid: The Latest in Diagnosis, Prognosis, and Therapy
Korman
Arch Dermatol 1998;134:1137-1141.
FULL TEXT  

Nicotinamide and Tetracycline Therapy of Bullous Pemphigoid
Fivenson et al.
Arch Dermatol 1994;130:753-758.
ABSTRACT  

Controlled Trial of Azathioprine and Plasma Exchange in Addition to Prednisolone in the Treatment of Bullous Pemphigoid
Guillaume et al.
Arch Dermatol 1993;129:49-53.
ABSTRACT  

The Treatment of Bullous Pemphigoid With Tetracycline and Niacinamide: A Preliminary Report
Berk and Lorincz
Arch Dermatol 1986;122:670-674.
ABSTRACT  

Liver Involvement in the Sulfone Syndrome
Johnson et al.
Arch Intern Med 1986;146:875-877.
ABSTRACT  

Localized Cicatricial Pemphigoid (Brunsting-Perry) A Transplantation Experiment
Ahmed et al.
Arch Dermatol 1984;120:932-935.
ABSTRACT  

Bullous Pemphigoid With Features of Prurigo Nodularis
Massa and Connolly
Arch Dermatol 1982;118:937-939.
ABSTRACT  

Commentary: Sulfoxone (Diasone) in the Treatment of Dermatitis Herpetiformis
Katz
Arch Dermatol 1982;118:809-812.
ABSTRACT  

Dapsone-Responsive, Noninfectious Verrucous Pyoderma: Its Occurrence Following Cisplatin Therapy
Person and Schwartz
Arch Dermatol 1982;118:336-338.
ABSTRACT  

Chronic Bullous Disease With Coexistent Circulating IgG and IgA Anti-Basement Membrane Zone Antibodies
Miyagawa et al.
Arch Dermatol 1981;117:349-353.
ABSTRACT  

Dapsone Hypersensitivity: The Sulfone Syndrome Revisited
Tomecki and Catalano
Arch Dermatol 1981;117:38-39.
ABSTRACT  

Pemphigus Vegetans: Its Relationship to Eosinophilic Spongiosis and Favorable Response to Dapsone
Pearson et al.
Arch Dermatol 1980;116:65-68.
ABSTRACT  

Polymorphic Pemphigoid
Honeyman et al.
Arch Dermatol 1979;115:423-427.
ABSTRACT  

Pemphigoid Vegetans
Winkelmann and Su
Arch Dermatol 1979;115:446-448.
ABSTRACT  

Unusual Subepidermal Bullous Diseases With Immunologic Features of Bullous Pemphigoid
Provost et al.
Arch Dermatol 1979;115:156-160.
ABSTRACT